The non-invasive test for SARS-CoV-2

Saliva testing can allow earlier detection to identify people who may not know they are contagious. In addition, because patients spit into a tube or cup, saliva testing is safer for healthcare workers than taking swabs. The greatest scientific advantage is that nasal and oral swabs only collect the surface area where the swab goes, which may not be the place with most viral load. In contrast, the virus occurs throughout a saliva sample, so the test is more trustworthy.

Using saliva to test for viral infection was not something previously tried therefore was not an FDA approved testing option. Swabs had been the traditional approved standard. As testing exponentially accelerated supplies became limited and it became clear additional options needed to be discovered. A groundbreaking study done by Rutgers University determined saliva to be 100% equal to swabs for COVID-19 detection and in many cases, it proved to be a better, more sensitive option. This was further validated by an additional study done by Yale University researchers.

This delivered EUA approval for Rutgers to use saliva for SARS-CoV- 2 testing based on the very specific and documents protocols they used.

What makes the Saliva collection unique:

  • Engineered to reduce at-home user and self-collection errors

  • Preservation chemistry is 100% bacteriostatic extending sample shelf-life

  • Consistently delivers higher quality and quantities of DNA for medical, genetic, and

    molecular diagnostic testing

  • Protects and suspends viral RNA transcripts for sensitive and specific analysis

  • Chemistry inactivates the live virus helping to shield healthcare professionals and

    clinicians from exposure

  • Proven to stabilize & protect SARS-CoV-2 viral RNA during specimen transport in all

    extreme temperatures for 14 days